These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23259790

  • 1. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
    Liu HB, Gu XL, Ma XQ, Lv TF, Wu Y, Xiao YY, Yuan DM, Li YF, Song Y.
    Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y, Wei S, Wang J, Hong L, Cui L, Wang C.
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [Abstract] [Full Text] [Related]

  • 3. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
    Fan Y, Du Y, Sun W, Wang H.
    Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
    [Abstract] [Full Text] [Related]

  • 4. Platelet distribution width correlates with prognosis of non-small cell lung cancer.
    Cui MM, Li N, Liu X, Yun ZY, Niu Y, Zhang Y, Gao B, Liu T, Wang RT.
    Sci Rep; 2017 Jun 14; 7(1):3456. PubMed ID: 28615714
    [Abstract] [Full Text] [Related]

  • 5. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
    Sulibhavi A, Asokan S, Miller MI, Moreira P, Daly BD, Fernando HC, Litle VR, Suzuki K.
    Ann Thorac Surg; 2020 Feb 14; 109(2):337-342. PubMed ID: 31593659
    [Abstract] [Full Text] [Related]

  • 6. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
    Ji Y, Sheng L, Du X, Qiu G, Su D.
    Platelets; 2015 Feb 14; 26(2):138-42. PubMed ID: 24679181
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of clinical N0 metastatic non-small cell lung cancer.
    Tamura T, Kurishima K, Watanabe H, Shiozawa T, Nakazawa K, Ishikawa H, Satoh H, Hizawa N.
    Lung Cancer; 2015 Jul 14; 89(1):71-5. PubMed ID: 25913230
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
    Gao L, Zhang H, Zhang B, Zhang L, Wang C.
    Oncotarget; 2017 Feb 28; 8(9):15632-15641. PubMed ID: 28152504
    [Abstract] [Full Text] [Related]

  • 9. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer.
    Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, Chen HG, Gu LJ.
    Med Oncol; 2013 Mar 28; 30(1):352. PubMed ID: 23275140
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
    Luo J, Song J, Feng P, Wang Y, Long W, Liu M, Li L.
    Tumour Biol; 2016 Aug 28; 37(8):10715-21. PubMed ID: 26873483
    [Abstract] [Full Text] [Related]

  • 11. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF, Wu P, Wu CP, Ji M, Wu J, Gu XF, Jiang ZX.
    Asia Pac J Clin Oncol; 2015 Dec 28; 11(4):e22-30. PubMed ID: 24889374
    [Abstract] [Full Text] [Related]

  • 12. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y, Su XD, Long H, Lin P, Fu JH, Zhang LJ, Wang X, Wen ZS, Zhu ZH, Zhang X, Rong TH.
    Chin J Cancer; 2010 May 28; 29(5):538-44. PubMed ID: 20426905
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 14. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW, Chen T, Yin S, Deng Y, Zhao B.
    Zhonghua Zhong Liu Za Zhi; 2018 Oct 23; 40(10):782-786. PubMed ID: 30392344
    [Abstract] [Full Text] [Related]

  • 15. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, Menekse S, Kocar M, Sen CA, Ordu C, Goksel G, Meydan N, Barutca S, Turkish Descriptive Oncological Researches Group.
    Clin Respir J; 2018 Mar 23; 12(3):922-929. PubMed ID: 28026133
    [Abstract] [Full Text] [Related]

  • 16. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
    Yang J, Peng A, Wang B, Gusdon AM, Sun X, Jiang G, Zhang P.
    Clin Exp Metastasis; 2019 Oct 23; 36(5):457-466. PubMed ID: 31420766
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K, Toyooka S, Soh J, Okami J, Higashiyama M, Kadota Y, Maeda H, Hayama M, Chida M, Funaki S, Okumura M, Miyoshi S.
    Interact Cardiovasc Thorac Surg; 2015 Jun 23; 20(6):791-6. PubMed ID: 25805399
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton AJ, Früh M.
    Lung Cancer; 2017 Sep 23; 111():176-181. PubMed ID: 28838390
    [Abstract] [Full Text] [Related]

  • 19. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1682-6. PubMed ID: 21914316
    [Abstract] [Full Text] [Related]

  • 20. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.
    Biomed Pharmacother; 2015 Oct 28; 75():185-90. PubMed ID: 26337230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.